
NASDAQ:PEP
This summary was created by AI, based on 7 opinions in the last 12 months.
PepsiCo (PEP) is experiencing challenges due to the rising popularity of GLP-1 weight-loss drugs among health-conscious consumers, especially the younger generation. Despite its long-standing Frito-Lay snack division and a solid dividend yield of nearly 4%, commentators express concerns about shifting consumer preferences impacting sales. The company reports earnings soon, and while some believe it has strong growth potential, others highlight struggles within the snack division. Activist investor Elliott Management's recent stake in PepsiCo suggests some see it as undervalued, viewing the current price as a bargain. However, there are underlying headwinds, including competition from healthier options and an overall cautious economic outlook that raises questions about future growth prospects.
PEP-Q vs. COKE-Q. He would be more inclined to take Pepsi as they diversified better and the growth has been better over the last few years.
He expects a great report from them on Thursday, because their snack business given them more consumer exposure than Coke has. Their last quarter was fine, but the market yawn from being bored with consumer staples. He bets their business is accelerating.
Allan Tong’s Discover Picks Analysts such as Jim Cramer would buy Pepsi stock now as the number of Covid cases could rise as the weather turns colder and more people stay at home to snack. Analysts expects its EPS to reach $1.50, which would return to last year’s levels. Pepsi pays a dividend just under 3%. The trailing PE has ballooned from 15.62x last December to the current 26.85x, which will give some investors pause. Read PEP and NVDA: 3 More Top Recognized ESG Investing Options for our full analysis.